Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Treatment Adherence on Efficacy of Dolutegravir + Lamivudine and Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Week 144 Analysis of the GEMINI-1 and GEMINI-2 Clinical Studies.
Fernvik E, Sierra Madero J, Espinosa N, Gulminetti R, Hagins D, Tsai HC, Man C, Sievers J, Grove R, Zolopa A, Wynne B, van Wyk J, Ait-Khaled M. Fernvik E, et al. Among authors: sierra madero j. J Acquir Immune Defic Syndr. 2023 Nov 1;94(3):e9-e12. doi: 10.1097/QAI.0000000000003280. J Acquir Immune Defic Syndr. 2023. PMID: 37850985 No abstract available.
Disease activity is associated with changes in the innate immune function in patients with systemic lupus erythematosus.
Torres-Ruiz J, Rull-Gabayet M, Mejía-Domínguez NR, Carrillo-Vázquez DA, Reyes-Islas JA, Cassiano-Quezada F, Cuellar-Rodríguez J, Sierra-Madero J, Sánchez JM, Serrano-García JS, González AE, Juárez-Vega G, Tapia-Rodríguez M, Gómez-Martín D. Torres-Ruiz J, et al. Among authors: sierra madero j. Clin Rheumatol. 2024 Jan;43(1):501-509. doi: 10.1007/s10067-023-06810-6. Epub 2023 Nov 15. Clin Rheumatol. 2024. PMID: 37964076
Adjuvant Topical Interferon Alpha 2b for the Treatment of Monkeypox Ocular Manifestations.
Arteaga-Rivera JY, Vigderovich-Cielak I, Ramirez-Miranda A, González A, Frías-Jimenez E, Arriaga-Guzman IE, Sierra Madero JG, Navas A, Graue-Hernandez EO. Arteaga-Rivera JY, et al. Among authors: sierra madero jg. Cornea. 2023 Dec 1;42(12):1578-1581. doi: 10.1097/ICO.0000000000003360. Epub 2023 Aug 23. Cornea. 2023. PMID: 37643461 Free PMC article.
Mexican perspective on the Mosaico HIV vaccine trial.
Crabtree Ramírez B, González Hernández LA, Cabrera C, Del Río C, González Rodríguez A, Sierra Madero J. Crabtree Ramírez B, et al. Among authors: sierra madero j. Lancet HIV. 2023 Jul;10(7):e426-e427. doi: 10.1016/S2352-3018(23)00114-5. Epub 2023 May 19. Lancet HIV. 2023. PMID: 37216956 No abstract available.
Burden and severity of mpox in Mexico 6 months into the outbreak.
Núñez I, Sierra-Madero J, Galindo-Fraga A, Ceballos-Liceaga SE, Reyes-Terán G, Valdés-Ferrer SI. Núñez I, et al. Among authors: sierra madero j. Clin Microbiol Infect. 2023 Jun;29(6):800-802. doi: 10.1016/j.cmi.2023.02.018. Epub 2023 Mar 5. Clin Microbiol Infect. 2023. PMID: 36871828 Free PMC article. No abstract available.
Predictors of laboratory-confirmed mpox in people with mpox-like illness.
Núñez I, Ceballos-Liceaga SE, de la Torre A, García-Rodríguez G, López-Martínez I, Sierra-Madero J, Mosqueda-Gómez JL, Valdés-Ferrer SI. Núñez I, et al. Among authors: sierra madero j. Clin Microbiol Infect. 2023 Dec;29(12):1567-1572. doi: 10.1016/j.cmi.2023.07.016. Epub 2023 Jul 29. Clin Microbiol Infect. 2023. PMID: 37524303
Development and content validity of EVAD: A novel tool for evaluating and classifying the severity of adverse events for psychotherapeutic clinical trials.
Mejía-Castrejón J, Sierra-Madero JG, Belaunzarán-Zamudio PF, Fresan-Orellana A, Molina-López A, Álvarez-Mota AB, Robles-García R. Mejía-Castrejón J, et al. Among authors: sierra madero jg. Psychother Res. 2024 Apr;34(4):475-489. doi: 10.1080/10503307.2023.2239448. Epub 2023 Aug 8. Psychother Res. 2024. PMID: 37552872 Review.
Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.
Belaunzarán-Zamudio PF, Naranjo L, Caro-Vega Y, Castillo-Mancilla JR, Camiro-Zuñiga A, Fuentes-García R, Crabtree-Ramírez BE, Sierra-Madero JG. Belaunzarán-Zamudio PF, et al. Among authors: sierra madero jg. AIDS Res Hum Retroviruses. 2023 Mar;39(3):136-144. doi: 10.1089/AID.2021.0179. Epub 2023 Feb 15. AIDS Res Hum Retroviruses. 2023. PMID: 36597354 Free PMC article.
Implementation of PrEP in Latin America.
Guerrero-Torres L, Sierra-Madero JG. Guerrero-Torres L, et al. Among authors: sierra madero jg. Lancet HIV. 2023 Feb;10(2):e70-e71. doi: 10.1016/S2352-3018(22)00370-8. Epub 2022 Dec 21. Lancet HIV. 2023. PMID: 36565707 No abstract available.
175 results